Abstract
The article presents the position of experts from the Joint Committee on Infant Hearing on the role of immunoprophylaxis in patients with cochlear implants. It emphasizes that viral and bacterial infections are a significant cause of sensorineural hearing loss, underscoring the importance of routine vaccination as a primary prevention method. In cochlear implants patients, surgery and the presence of the implant create additional risks of infectious complications, including acute otitis media and meningitis. Particular attention is paid to the necessity of vaccination against pneumococcal, Haemophilus influenzae type b infections, as well as influenza. The authors recommend assessing vaccination status before and after surgery, administering immunizations according to the National Immunization Schedule, and implementing an individual schedule for high-risk groups. Specific vaccination regimens are provided, including the combined use of pneumococcal conjugate and polysaccharide vaccines. It is concluded that strategically sound immunoprophylaxis is a key factor in minimizing risks and enhancing the effectiveness of auditory-speech rehabilitation.

This publication has 34 references indexed in Scilit: